Search Results - "Mikami, Ayako"

Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals by Maeda, Kenji, Amano, Masayuki, Uemura, Yukari, Tsuchiya, Kiyoto, Matsushima, Tomoko, Noda, Kenta, Shimizu, Yosuke, Fujiwara, Asuka, Takamatsu, Yuki, Ichikawa, Yasuko, Nishimura, Hidehiro, Kinoshita, Mari, Matsumoto, Shota, Gatanaga, Hiroyuki, Yoshimura, Kazuhisa, Oka, Shin-ichi, Mikami, Ayako, Sugiura, Wataru, Sato, Toshiyuki, Yoshida, Tomokazu, Shimada, Shinya, Mitsuya, Hiroaki

“…While mRNA vaccines against SARS-CoV-2 are exceedingly effective in preventing symptomatic infection, their immune response features remain to be clarified. In…”
Get full text

Inhaled GM-CSF for Pulmonary Alveolar Proteinosis by Tazawa, Ryushi, Ueda, Takahiro, Abe, Mitsuhiro, Tatsumi, Koichiro, Eda, Ryosuke, Kondoh, Shotaro, Morimoto, Konosuke, Tanaka, Takeshi, Yamaguchi, Etsuro, Takahashi, Ayumu, Oda, Miku, Ishii, Haruyuki, Izumi, Shinyu, Sugiyama, Haruhito, Nakagawa, Atsushi, Tomii, Keisuke, Suzuki, Masaru, Konno, Satoshi, Ohkouchi, Shinya, Tode, Naoki, Handa, Tomohiro, Hirai, Toyohiro, Inoue, Yoshikazu, Arai, Toru, Asakawa, Katsuaki, Sakagami, Takuro, Hashimoto, Atsushi, Tanaka, Takahiro, Takada, Toshinori, Mikami, Ayako, Kitamura, Nobutaka, Nakata, Koh

“…In patients with autoimmune pulmonary alveolar proteinosis, the use of inhaled recombinant granulocyte–macrophage colony-stimulating factor resulted in a…”
Get full text

Mechanisms for the α-Adrenoceptor-Mediated Positive Inotropy in Mouse Ventricular Myocardium: Enhancing Effect of Action Potential Prolongation by Hamaguchi, Shogo, Morinou, Ikue, Shiseki, Yuko, Mikami, Ayako, Seki, Maika, Namekata, Iyuki, Tanaka, Hikaru

“…Mechanisms for the α-adrenoceptor-mediated positive inotropy in neonatal mouse ventricular myocardium were studied with isolated myocardial preparations. The…”
Get full text

Clinical trial experience in Japan and future issues in developing drugs to treat COVID-19 by Mikami, Ayako, Terada-Hirashima, Junko, Tokita, Daisuke, Sugiura, Wataru

“…The National Center for Global Health and Medicine plays a central role in the treatment and research of infectious diseases in Japan. It has conducted various…”
Get full text

Major ongoing clinical trials for COVID-19 treatment and studies currently being conducted or scheduled in Japan by Ito, Kyoji, Ohmagari, Norio, Mikami, Ayako, Sugiura, Wataru

“…The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a serious threat to global…”
Get full text

Energy-Saving and CO2-Emissions-Reduction Potential of a Fuel Cell Cogeneration System for Condominiums Based on a Field Survey by Yoshida, Kazui, Rijal, Hom B., Bohgaki, Kazuaki, Mikami, Ayako, Abe, Hiroto

“…A residential cogeneration system (CGS) is highlighted because of its efficient energy usage on both the supplier and consumer sides. It generates electricity…”
Get full text

Field Study on Energy-Saving Behaviour and Patterns of Air-Conditioning Use in a Condominium by Yoshida, Kazui, Rijal, Hom B., Bogaki, Kazuaki, Mikami, Ayako, Abe, Hiroto

“…In the international movement to combat the threat of climate change, the timely implementation of residential energy-saving practises is becoming an urgent…”
Get full text

Impact of inhaled ciclesonide on asymptomatic or mild COVID-19: A randomized trial by Terada-Hirashima, Junko, Suzuki, Manabu, Tsujimoto, Yoshie, Hamamoto, Yoichiro, Uemura, Yukari, Tsushima, Kenji, Inoue, Hideki, Komatsu, Shigeru, Saito, Zenya, Tsuzuki, Ryuta, Okamoto, Masaki, To, Yasuo, Moriya, Kyoji, Yoshizawa, Sadako, Tanaka, Masahide, Muto, Toshitaka, Mikami, Ayako, Takasaki, Jin, Izumi, Shinyu, Ohmagari, Norio, Hojo, Masayuki, Sugiura, Wataru, Sugiyama, Haruhito

“…The aim of this study was to determine the efficacy and safety of ciclesonide in the treatment of novel coronavirus disease 2019 (COVID-19) as gauged by…”
Get full text

Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan by Terada-Hirashima, Junko, Takamatsu, Yuki, Shimizu, Yosuke, Uemura, Yukari, Takeuchi, Junko S., Tomita, Noriko, Matsuda, Kouki, Maeda, Kenji, Yamamoto, Shohei, Fukunaga, Ami, Ohmagari, Norio, Mikami, Ayako, Sonoda, Kengo, Ujiie, Mugen, Mitsuya, Hiroaki, Sugiura, Wataru

“…Although vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease 2019 (COVID-19) induce effective immune responses, vaccination with…”
Get full text

Investigator initiated clinical trial of remdesivir for the treatment of COVID-19 in Japan by Saito, Sho, Hayakawa, Kayoko, Mikami, Ayako, Izumi, Shinyu, Funazaki, Hideki, Ashida, Shinobu, Sugiura, Wataru, Sugiyama, Haruhito, Kokudo, Norihiro, Ohmagari, Norio

“…Coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) originating in Wuhan, China, has spread globally very…”
Get full text

Inhaled GM-CSF for Pulmonary Alveolar Proteinosis by Tazawa, Ryushi, Ueda, Takahiro, Abe, Mitsuhiro, Tatsumi, Koichiro, Eda, Ryosuke, Kondoh, Shotaro, Morimoto, Konosuke, Tanaka, Takeshi, Yamaguchi, Etsuro, Takahashi, Ayumu, Oda, Miku, Ishii, Haruyuki, Izumi, Shinyu, Sugiyama, Haruhito, Nakagawa, Atsushi, Tomii, Keisuke, Suzuki, Masaru, Konno, Satoshi, Ohkouchi, Shinya, Tode, Naoki, Handa, Tomohiro, Hirai, Toyohiro, Inoue, Yoshikazu, Arai, Toru, Asakawa, Katsuaki, Sakagami, Takuro, Hashimoto, Atsushi, Tanaka, Takahiro, Takada, Toshinori, Mikami, Ayako, Kitamura, Nobutaka, Nakata, Koh

Get full text

Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial by Saito, Sho, Kutsuna, Satoshi, Akifumi, Imamura, Hase, Ryota, Oda, Rentaro, Terada, Junko, Shimizu, Yosuke, Uemura, Yukari, Takamatsu, Yuki, Yasuhara, Akemi, Shiratori, Katsuyuki, Satake, Masahiro, Sakamoto, Naoya, Miyazaki, Yasunari, Shimizu, Hidefumi, Togano, Tomiteru, Matsunaga, Akihiro, Okuma, Kazu, Hamaguchi, Isao, Fujisawa, Kyoko, Nagashima, Maki, Ashida, Shinobu, Terada, Mari, Kimura, Akiko, Morioka, Shinichiro, Matsubayashi, Keiji, Tsuno, Nelson Hirokazu, Kojima, Makiko, Kuramitsu, Madoka, Tezuka, Kenta, Ikebe, Emi, Ishizaka, Yukihito, Kenji, Maeda, Hangaishi, Akira, Mikami, Ayako, Sugiura, Wataru, Ohmagari, Norio, Mitsuya, Hiroaki

“…Convalescent plasma is a potential therapeutic option for patients with coronavirus disease 2019 (COVID-19). Despite its use for treating several viral…”
Get full text

Efficacy and Safety of Direct Hemoperfusion Using Polymyxin B-Immobilized Polystyrene Column for Patients With COVID-19: Protocol for an Exploratory Study by Terada-Hirashima, Junko, Izumi, Shinyu, Katagiri, Daisuke, Uemura, Yukari, Mikami, Ayako, Sugiura, Wataru, Abe, Shinji, Azuma, Arata, Sugiyama, Haruhito

“…Background Polymyxin B-immobilized fiber column (PMX; Toraymyxin column) was approved for the relief of systemic inflammatory response syndrome caused by…”
Get full text

Protocol of an Exploratory Single-Arm Study to Evaluate the Safety and Immunogenicity of KD-414 as a Booster Vaccine for SARS-CoV-2 in Healthy Adults (KAPIVARA) by Terayama, Yuriko, Tomita, Noriko, Terada-Hirashima, Junko, Uemura, Yukari, Shimizu, Yosuke, Takeuchi, Junko S, Takamatsu, Yuki, Maeda, Kenji, Mikami, Ayako, Ujiie, Mugen, Sugiura, Wataru

“…The coronavirus disease 2019 (COVID-19) pandemic is currently ongoing, and there have been significant efforts in the development of COVID-19 vaccines…”
Get full text

A Multi-Center, Open-Label, Randomized Controlled Trial to Evaluate the Efficacy of Convalescent Plasma Therapy for Coronavirus Disease 2019: A Trial Protocol (COVIPLA-RCT) by Tomita, Noriko, Saito, Sho, Terada-Hirashima, Junko, Mikami, Ayako, Uemura, Yukari, Kutsuna, Satoshi, Nomoto, Hidetoshi, Fujisawa, Kyoko, Nagashima, Maki, Terada, Mari, Ashida, Shinobu, Morioka, Shinichiro, Satake, Masahiro, Hangaishi, Akira, Togano, Tomiteru, Shiratori, Katsuyuki, Takamatsu, Yuki, Maeda, Kenji, Ohmagari, Norio, Sugiura, Wataru, Mitsuya, Hiroaki

“…Coronavirus disease 2019 is a global public health concern. As of December 2020, the therapeutic agents approved for coronavirus disease 2019 in Japan were…”
Get full text

Benefit of extending the dosing interval of long‐acting antipsychotic injections in elderly schizophrenics with cognitive dysfunction by Suzuki, Hidenobu, Hibino, Hiroyuki, Inoue, Yuichi, Mikami, Ayako, Matsumoto, Hideo, Mikami, Katsunaka

Get full text

Validation of a new serum granulocyte-macrophage colony-stimulating factor autoantibody testing kit by Nakata, Koh, Sugi, Tatsuki, Kuroda, Keiko, Yoshizawa, Kazutaka, Takada, Toshinori, Tazawa, Ryushi, Ueda, Takahiro, Aoki, Ami, Abe, Mitsuhiro, Tatsumi, Koichiro, Eda, Ryosuke, Kondoh, Shotaro, Morimoto, Konosuke, Tanaka, Takeshi, Yamaguchi, Etsuro, Takahashi, Ayumu, Oda, Miku, Ishii, Haruyuki, Izumi, Shinyu, Sugiyama, Haruhito, Nakagawa, Atsushi, Tomii, Keisuke, Suzuki, Masaru, Konno, Satoshi, Ohkouchi, Shinya, Hirano, Taizou, Handa, Tomohiro, Hirai, Toyohiro, Inoue, Yoshikazu, Arai, Toru, Asakawa, Katsuaki, Sakagami, Takuro, Tanaka, Takahiro, Mikami, Ayako, Kitamura, Nobutaka

“…Very recently, a modest but significant efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) inhalation therapy for the treatment of mild to…”
Get full text

Benefits associated with switching from benzodiazepine hypnotics to suvorexant in patients with mild primary insomnia by Suzuki, Hidenobu, MD, PhD, Hibino, Hiroyuki, MD, Inoue, Yuichi, MD, Mikami, Ayako, MD, PhD, Matsumoto, Hideo, MD, PhD, Mikami, Katsunaka, MD, PhD

Get full text

Study of the efficacy and safety of switching from risperidone to paliperidone in elderly patients with schizophrenia by Suzuki, Hidenobu, Gen, Keishi, Otomo, Masahiro, Inoue, Yuichi, Hibino, Hiroyuki, Mikami, Ayako, Matsumoto, Hideo, Mikami, Katsunaka

“…Aim We investigated the clinical efficacy and safety of switching to paliperidone (PAL) in elderly schizophrenia patients receiving risperidone. Methods The…”
Get full text

Synthesis and structure–activity relationships of potent 4-fluoro-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors by Fukushima, Hiroshi, Hiratate, Akira, Takahashi, Masato, Mikami, Ayako, Saito-Hori, Masako, Munetomo, Eiji, Kitano, Kiyokazu, Chonan, Sumi, Saito, Hidetaka, Suzuki, Akio, Takaoka, Yuji, Yamamoto, Koji

“…We report the identification of a potent and stable DPP-IV inhibitor (TS-021) with a long-term persistent plasma drug concentration and a potent…”
Get full text